ProScribe Medical Communications, Brisbane, Australia.
Ann Pharmacother. 2013 Jul-Aug;47(7-8):1084-7. doi: 10.1345/aph.1S178. Epub 2013 Jun 25.
In this commentary, we present evidence that unethical authorship (eg, guest and ghost authoring) and other publication practices are not restricted to the pharmaceutical industry; they also occur in academia. Such practices are not an industry problem--they are a research problem. To enhance trust in industry-sponsored research, companies have made rapid and far-reaching changes to their publication guidelines, policies, and procedures. Professional medical writers have adopted, and continue to implement, these changes. Although evidence indicates that industry practices are improving, there is certainly more to do, both in industry and academia. We invite readers to join ongoing efforts to promote ethical publication practices.
在这篇评论中,我们提出证据表明,不道德的作者身份(例如客座作者和幽灵作者)和其他出版做法不仅限于制药行业;它们也存在于学术界。这些做法不是行业问题——它们是研究问题。为了提高对行业赞助研究的信任,公司已经对其出版指南、政策和程序进行了快速和深远的改变。专业的医学作家已经采用并继续实施这些变化。尽管有证据表明行业做法正在改善,但在行业和学术界都还有很多工作要做。我们邀请读者加入正在进行的努力,以促进道德出版实践。
J Korean Med Sci. 2018-10-18
Am J Ophthalmol. 2008-9
Curr Med Res Opin. 2010-6
Am J Ophthalmol. 2009-1
Clin Dermatol. 2012
Indian Pediatr. 2021-8-15
Pan Afr Med J. 2018-7-18